LYMPHOMATOID PAPULOSIS
Clinical trials for LYMPHOMATOID PAPULOSIS explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMATOID PAPULOSIS trials appear
Sign up with your email to follow new studies for LYMPHOMATOID PAPULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
First-in-Human trial tests 'Supercharged' immune cells to hunt lymphoma
Disease control OngoingThis is a first-in-human study to test the safety of a new type of engineered immune cell therapy for adults with specific lymphomas that have returned or not responded to prior treatments. Researchers modify a patient's own T-cells to better recognize and attack cancer cells car…
Matched conditions: LYMPHOMATOID PAPULOSIS
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Targeted therapy tested for Hard-to-Treat skin cancers
Disease control OngoingThis study tested whether the drug brentuximab vedotin could help control three types of CD30-positive skin lymphomas in patients whose disease had come back or did not respond to prior treatments. The drug is designed to find and enter cancer cells with a specific marker (CD30) …
Matched conditions: LYMPHOMATOID PAPULOSIS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC